Shuiping Yu

2.1k total citations
24 papers, 577 citations indexed

About

Shuiping Yu is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Shuiping Yu has authored 24 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Hepatology. Recurrent topics in Shuiping Yu's work include Epigenetics and DNA Methylation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Shuiping Yu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Shuiping Yu collaborates with scholars based in China and United States. Shuiping Yu's co-authors include Songqing He, Zhenran Wang, Guangying Qi, Shengguang Yuan, Xingsi Liang, Bo Tang, Biao Lei, Fang Tang, Bo Tang and Yangchao Wei and has published in prestigious journals such as Cancer Research, Scientific Reports and Cell Research.

In The Last Decade

Shuiping Yu

23 papers receiving 570 citations

Peers

Shuiping Yu
Jichao Wei China
Yufan Zheng China
Liansheng Gong China
Manqing Cao China
Jianjiang Fu China
Xuan Zhu China
Xingsi Liang China
Danyu Du China
Jichao Wei China
Shuiping Yu
Citations per year, relative to Shuiping Yu Shuiping Yu (= 1×) peers Jichao Wei

Countries citing papers authored by Shuiping Yu

Since Specialization
Citations

This map shows the geographic impact of Shuiping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuiping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuiping Yu more than expected).

Fields of papers citing papers by Shuiping Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuiping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuiping Yu. The network helps show where Shuiping Yu may publish in the future.

Co-authorship network of co-authors of Shuiping Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuiping Yu. A scholar is included among the top collaborators of Shuiping Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuiping Yu. Shuiping Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Shuyun, et al.. (2025). Liver resection in stage 0-A HCC in segments 7/8: a propensity-matched analysis comparing open, laparoscopic, and robotic approach. Surgical Endoscopy. 39(3). 1902–1914. 2 indexed citations
2.
Yuan, Guandou, et al.. (2024). FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway. Scientific Reports. 14(1). 21135–21135.
3.
Lei, Biao, et al.. (2024). C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients. World Journal of Gastrointestinal Oncology. 16(1). 61–78. 3 indexed citations
4.
Lin, Chengjie, Biao Lei, Shilian Chen, et al.. (2023). Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling. American Journal of Transplantation. 23(4). 484–497. 5 indexed citations
5.
Yu, Shuiping, et al.. (2022). Application of da Vinci robot and laparoscopy on repeat hepatocellular carcinoma. Journal of Minimal Access Surgery. 18(3). 378–383. 2 indexed citations
6.
Guo, Wei, Xiaofei Ye, Ming Wang, et al.. (2022). Comparison of surgical outcomes among open, laparoscopic, and robotic pancreatoduodenectomy: a single-center retrospective study. BMC Surgery. 22(1). 348–348. 17 indexed citations
7.
He, Xiang, et al.. (2022). Da Vinci robot-assisted pancreato-duodenectomy in a patient with situs inversus totalis: A case report and review of literature. World Journal of Gastrointestinal Oncology. 14(7). 1363–1371. 1 indexed citations
8.
Zhong, Fudi, Zhigao Hu, Biao Lei, et al.. (2019). Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis. Cell Research. 29(7). 548–561. 73 indexed citations
9.
Tang, Bo, Yu Tian, Yong Liao, et al.. (2019). CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma. Cell Death and Disease. 10(2). 52–52. 27 indexed citations
10.
Yu, Shuiping, et al.. (2018). Surgery strategy of 13 cases to control bleeding from the liver on laparoscopic repeat liver resection for recurrent hepatocellular carcinoma. Journal of Minimal Access Surgery. 15(3). 214–214. 6 indexed citations
11.
Yu, Shuiping, et al.. (2017). Model Study for Intelligent Transportation System with Big Data. Procedia Computer Science. 107. 418–426. 18 indexed citations
12.
Tang, Bo, Guangying Qi, Fang Tang, et al.. (2016). Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell–Like Behaviors in Hepatocellular Carcinoma. Cancer Research. 76(22). 6520–6532. 71 indexed citations
13.
Tang, Bo, Fang Tang, Zhenran Wang, et al.. (2016). Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling. Journal of Experimental & Clinical Cancer Research. 35(1). 82–82. 48 indexed citations
14.
Tang, Bo, Biao Lei, Guangying Qi, et al.. (2016). MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression. Journal of Experimental & Clinical Cancer Research. 35(1). 93–93. 50 indexed citations
15.
Tang, Bo, Fang Tang, Zhenran Wang, et al.. (2016). Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle. International Journal of Nanomedicine. Volume 11. 6401–6420. 89 indexed citations
16.
17.
Tang, Bo, Yang Li, Guangying Qi, et al.. (2015). Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer. Scientific Reports. 5(1). 13563–13563. 45 indexed citations
18.
Tang, Bo, Guangying Qi, Fang Tang, et al.. (2015). JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells. Oncotarget. 6(14). 12723–12739. 59 indexed citations
19.
Yu, Shuiping, et al.. (2014). Metastasis of the liver with a granulosa cell tumor of the ovary: A case report. Oncology Letters. 9(2). 816–818. 10 indexed citations
20.
Tang, Bo, et al.. (2013). Alpinetin down-regulating Bcl-2 promotes apoptosis of human hepatic cancer Hep3B cells. Zhonghua putong waike zazhi. 28(7). 542–545. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jichao Wei Breakdown of academic impact, for papers by Yufan Zheng Breakdown of academic impact, for papers by Liansheng Gong Breakdown of academic impact, for papers by Manqing Cao Breakdown of academic impact, for papers by Jianjiang Fu Breakdown of academic impact, for papers by Xuan Zhu Breakdown of academic impact, for papers by Xingsi Liang Breakdown of academic impact, for papers by Danyu Du
Rankless by CCL
2026